A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 18, Issue 1, 2007, Pages 103-112

  Tchekneva, Elena E ^a   Rinchik, Eugene M ^d,e,f   Polosukhina, Dina ^a   Davis, Linda S ^a   Kadkina, Veronika ^a   Mohamed, Yassir ^a   Dunn, Steve R ^g   Sharma, Kumar ^g   Qi, Zhonghua ^a   Fogo, Agnes B ^a   Breyer, Matthew D ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d OAK RIDGE NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF TENNESSEE   (United States)

^f Taconic Farms Inc   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; ETHYLNITROSOUREA; INULIN; UREA;

ADOLESCENT; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HEREDITY; HISTOPATHOLOGY; INBRED STRAIN; INS2 GENE; INSULIN DEPENDENT DIABETES MELLITUS; INULIN CLEARANCE; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

EID: 33846037745     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006020164     Document Type: Article

References (50)

1. Szczech LA, Lazar IL: Projecting the United States ESRD population: Issues regarding treatment of patients with ESRD. Kidney Int Suppl 90: S3-S7, 2004
2. Young BA, Maynard C, Boyko EJ: Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26: 2392-2399, 2003
3. Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH: Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 23: 30-33, 2000
4. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin dependent diabetes mellitus. N Engl J Med 332: 1251-1255, 1995
5. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
6. Krolewski AS: Genetics of diabetic nephropathy: Evidence for major and minor gene effects. Kidney Int 55: 1582-1596, 1999
7. Iyengar SK, Fox KA, Schachere M, Manzoor F, Slaughter ME, Covic AM, Orloff SM, Hayden PS, Olson JM, Schelling JR, Sedroe JR: Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol 14[Suppl 2]: S195-S201, 2003
8. Knowler WC, Coresh J, Elston RC, Freedman BI, Iyengar SK, Kimmel PL, Olson JM, Plaetke R, Sedor JR, Seidin MF; Family Investigation of Nephropathy and Diabetes Research Group: The Family Investigation of Nephropathy and Diabetes (FIND): Design and methods. J Diabetes Complications 19: 1-9, 2005
9. Mueller PW, Rogus JJ, Cleary PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH: Genetics of Kidneys in Diabetes (GoKinD) study: A genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 17: 1782-1790, 2006
10. Qi Z, Fujita H, Jin J, Davis LS, Wang Y, Fogo AB, Breyer MD: Characterization of susceptibility if inbred mouse strains to diabetic nephropathy. Diabetes 54: 2628-2637, 2005
11. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM: Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290: F214-F222, 2006
12. Kakoki M, Takahashi N, Jennette JC, Smithies O: Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A 101: 13302-13305, 2004
13. Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA: Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: Role of advanced glycation end products. J Am Soc Nephrol 15: 2125-2138, 2004
14. Russell WL, Kelly EM, Hunsicker PR, Bangham JW, Maddux SC, Phipps EL: Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci U S A 76: 5818-5819, 1979
15. Nadeau JH, Frankel WN: The roads from phenotyping variation to gene discovery: Mutagenesis versus QTLs. Nat Genet 25: 381-384, 2000
16. Beier DR: Sequence-based analysis of mutagenized mice. Mamm Genome 11: 594-597, 2000
17. Nolan PM, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray IC, Vizor L, Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu X, McCormack X, Pickford K, Selley R, Wells C, Tymowska-Lalanne Z, Roby P, Glenister P, Thornton C, Thaung C, Stevenson J-A, Arkell R, Mburu P, Hardisty R, Kiernan A, Erven A, Steel KP, Voegeling S, Guenet J-L, Nickols C, Sadri R, Naase M, Isaacs A, Davies K, Browne M, Fisher EMC, Martin J, Rastan S, Brown SDM, Hunter J: A systematic, genome wide, phenotype-driven mutagenesis program for gene function studies in the mouse. Nat Genet 25: 440-443, 2000
18. Hrabe de Angelis M, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, Marschall S, Heffner S, Pargent W, Wuensch K, Jung M, Reis A, Richter T, Alessandrini A, Jakob T, Fuchs E, Kolb H, Kremmer E, Schaeble K, Rollinski B, Roscher A, Peters C, Meitinger T, Strom T, Steckler T, Holsboer F, Klopstock T, Gekeler F, Schindewolf C, Jung T, Avraham K, Behrendt H, Ring J, Zimmer A, Schughart K, Pfeffer K, Wolf E, Balling R: Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25: 444-447, 2000
19. Wang J, Takeuchi T, Tanaka S, Kubo S-K, Kayo T, Lu D, Takata K, Koizumi A, Izumi T: A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103: 27-37, 1999
20. Justice MJ, Carpenter DA, Favor J, Neuhauser-Klaus A, Hrabe de Angelis M, Soewarto D, Moser A, Cordes S, Miller D, Chapman V, Weber JS, Rinchik EM, Hunsicker PR, Russell WL, Bode VC: Effects of ENU dosage on mouse strains. Mamm Genome 11: 484-488, 2000
21. Hem A, Smith AJ, Solberg P: Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 32: 364-368, 1998
22. Lorenz JN, Gruenstein E: A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. Am J Physiol 276: F172-F177, 1999
23. Qi Z, Whitt I, Mehta A, Jin J, Zhao M: Harris RC, Fogo AB, Breyer MD: Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol 286: 590-596, 2004
24. Dunn SR, Qi Z: Bottinger EP, Breyer MD: Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int 56: 1959-1967, 2004
25. Raji L, Azar S, Keane W: Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984
26. Cowie CC, Port FK, Wolf RA, Savage PJ, Moll PP, Hawthorne VM: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321: 1074-1079, 1989
27. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945, 1996
28. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL: Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 49: 1049-1056, 2000
29. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, Van Der Woude FJ, Janssen B: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183, 2002
30. Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS: Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): A sex-specific effect. Diabetes 54: 3331-3335, 2005
31. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, Koya D, Babazono T, Tanaka Y, Matsuda M: Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54: 1171-1178, 2005
32. Yoshioka M, Kayo T, Ikeda T, Koizumi A: A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46: 887-894, 1997
33. Caramori ML, Fioretto P, Mauer M: The need for earlier predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes 49: 1399-1408, 2000
34. Mogensen CE: The effect of blood pressure intervention on renal function in insulin-dependent diabetes. Diabetes Metab 15: 343-351, 1989
35. Mogensen CE: Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 254: 45-66, 2003
36. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW: Nephropathy in diabetes. Diabetes Care 27[Suppl 1]: S79-S83, 2004
37. Breyer MD, Bottinger E, Brosius III FC, Coffman TM, Harris RC, Heilig CW, Sharma K; AMDCC: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005
38. Fujita H, Haseyama T, Kayo T, Nozaki J, Wada Y, Ito S, Koizumi A: Increased expression of glutathione S-transferase in renal proximal tubules in the early stages of diabetes: A study of type-2 diabetes in the Akita mouse model. Exp Nephrol 9: 380-386, 2001
39. Sharma K, McCue P, Dunn SR: Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003
40. Arakawa K, Ishihara T, Oku A, Nawano M, Ueta K, Kitamura K, Matsumoto M, Saito A: Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095. Br J Pharmacol 132: 578-586, 2001
41. Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN: Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53: 3248-3257, 2004
42. Tchekneva EE, Qi Z, Polosukhina D, Jin J, Breyer MD: A cyclooxygenase-1 (COX-1) selective inhibitor improves diabetic nephropathy in mice [Abstract]. J Am Soc Nephrol 14: 393A, 2003
43. Mauer SM, Lane P, Zhu D, Fioretto P, Steffes MW: Renal structure and function in insulin-dependent diabetes mellitus in man. J Hypertens Suppl 10: S17-S20, 1992
44. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type 1 diabetes without overt proteinuria. N Engl J Med 320: 966-970, 1989
45. Guo M, Ricardo SD, Deane JA, Shi M, McEwen LC, Bertram JF: A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat 207: 813-821, 2005
46. Carlson EC, Audette JL, Veitenheimer NJ, Risan JA, Laturnus DI, Epstein PN: Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. Anat Rec A Discov Mol Cell Evol Biol 271: 332-341, 2003
47. DeFronzo RA: Diabetic nephropathy. In: Ellenberg & Rifkin's Diabetes Mellitus, edited by Porte D, Sherwin RS, Baron A, New York, McGraw Hill, 2004, pp 723-745
48. Krolewski AS, Warram JH, Christlieb AR: Hypercholesterolemia: A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int Suppl 45: S125-S131, 1994
49. Thomas MC, Rosengard-Barlund M, Mills V, Ronnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH: Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care 29: 317-322, 2006
50. Wang Y, Zhou J, Minto AW, Hack BK, Alexander JJ, Haas M, Li YC, Heilig CW, Quigg RJ: Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int 70: 882-891, 2006